{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-155640","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2022-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.701100+00:00","generated_at":"2026-06-25T08:44:07.957168+00:00","sec_items":["2.01","5.02"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cortexyme completes Novosteo acquisition for ~6M shares; CLO departing","bullets":["Completed merger with Novosteo; each Novosteo share converted to 0.0911 Cortexyme shares.","Issued approximately 6 million shares (including options covering 507,108 shares) as consideration.","Caryn McDowell, Chief Legal and Administrative Officer, to depart effective July 8, 2022.","McDowell receives $339,000 cash severance, accelerated vesting, and extended option exercise period.","Additional severance and benefits if change in control occurs within 3 months after departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-155640","json":"https://secwatch.observer/filing/0001193125-22-155640.json","markdown":"https://secwatch.observer/filing/0001193125-22-155640.md","text":"https://secwatch.observer/filing/0001193125-22-155640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312522155640/0001193125-22-155640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312522155640/d334868d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:44:07.957168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b637ae323","claim":"Caryn McDowell departed as Chief Legal and Administrative Officer and Corporate Secretary at Quince Therapeutics, Inc..","evidence_excerpt":"On May 20, 2022, the Company announced the departure of Caryn McDowell, the Company’s Chief Legal and Administrative Officer and Corporate Secretary, effective as of July 8, 2022 (the “Departure Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662774/000119312522155640/0001193125-22-155640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Legal and Administrative Officer and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}